WonderBiotics vs Ritual Synbiotic+: Best for GLP-1 Users?

WonderBiotics Probiotics for Gut Health vs Ritual Synbiotic+: Which Fits GLP-1 Digestion Better?

If bloating or constipation from semaglutide or tirzepatide is what sent you looking, WonderBiotics Probiotics for Gut Health is built around that specific situation, with a 12-strain, 60-billion-CFU blend plus a digestive enzyme complex. Ritual Synbiotic+ is a well-made two-strain synbiotic, but it isn't formulated or marketed with GLP-1 users in mind. Neither has been tested in a published trial of people actually taking these drugs, which matters for how you should read either brand's claims.

What's Actually Inside Ritual Synbiotic+

Ritual's product page lists a fairly lean formula for a "3-in-1" synbiotic¹. The probiotic portion is 40 mg (11 billion CFU) of two strains: Lacticaseibacillus rhamnosus (branded LGG®) and Bifidobacterium animalis subsp. lactis (branded BB-12®). Both are long-standing commercial strains that show up across many probiotic categories. Ritual's own product description calls them "two of the world's most clinically-studied strains, with over 100+ publications of human clinical trials"¹ — that's the brand's characterization of the strains' overall research history, rather than a claim about a specific published trial on this exact capsule.

Alongside the probiotic blend, Synbiotic+ adds two ingredients most competitors skip. PreforPro® (15 mg) is a bacteriophage blend — four specific phages (LH01, LL5, T4D, LL12) that Ritual describes as designed to target certain gram-negative bacteria to help make room for beneficial species. Tributyrin, sold under the name CoreBiome® (300 mg), is a postbiotic that delivers butyrate, the short-chain fatty acid colon cells use as fuel, without relying on fiber fermentation to produce it¹.

The capsule itself is a delayed-release, acid-resistant vegan capsule engineered to survive stomach acid and release in the colon, and it comes with a small mint-scented tab attached to mask the smell. Dosing is one capsule a day, with or without food. A one-time 30-count bottle runs $61.36 plus $10.99 shipping, for a total of $72.35; subscribing drops the first order to $43.20, a discount off the $54 list price, then renews at $54 a month with free shipping¹. Nowhere on Ritual's product page is there any mention of GLP-1 medications, semaglutide, Ozempic, Wegovy, or Mounjaro. This is a general gut-health product, not one positioned for this specific use case.

What's Actually Inside WonderBiotics Probiotics for Gut Health

WonderBiotics Probiotics for Gut Health takes a broader-spectrum approach: 12 strains totaling 60 billion CFU per capsule, including Bifidobacterium animalis subsp. lactis HN019, Lactobacillus acidophilus NCFM, Lacticaseibacillus rhamnosus GG, Lactococcus lactis Ll-23, Lacticaseibacillus casei Lc-11, Lacticaseibacillus paracasei Lpc-37, Lactiplantibacillus plantarum Lp-115, Bifidobacterium lactis DSM15954, Ligilactobacillus salivarius Ls-33, Levilactobacillus brevis Lbr-35, Limosilactobacillus fermentum SBS-1, and Bifidobacterium breve Bb-02². On top of the strain blend, the formula includes a multi-enzyme complex (reported elsewhere as alpha amylase, neutral protease, lactase, cellulase, and lipase) and fructooligosaccharides (FOS) as a prebiotic to feed the bacteria.

We built it this way because GLP-1 users aren't just short on good bacteria. Delayed gastric emptying means food sits in the stomach longer, and a lot of people describe meals feeling "heavier" to digest on these drugs. The formula pairs a digestive enzyme blend with a strain count and CFU total higher than most competing gut formulas, so HN019 and NCFM, our two lead strains for GLP-1 users, aren't working alone. The enzyme blend hasn't been tested in a GLP-1 population, but it's designed to support the chemical breakdown of food, alongside the microbial side the strains handle. Dosing is one capsule daily, taken within 30 minutes after a meal. Pricing is $44.30 for a one-time order, with subscription options bringing it down to roughly $33–38 a month².

Our FAQ addresses GLP-1 users directly, describing Gut Health as built for people on Ozempic, Wegovy, or Mounjaro, with HN019 and NCFM named as the formula's lead strains for that purpose². HN019 does have published human trials behind it, but that research was done in general adult populations with functional GI symptoms, not in people taking GLP-1 medications, and the results are more mixed than a single strain callout can capture.

Does Either Formula Have Evidence for GLP-1-Related Bloating and Constipation?

The strain-level research breaks down like this.

HN019 (in WonderBiotics Gut Health). A 100-person, 14-day trial gave adults who reported one to three bowel movements a week either a high dose (17.2 billion CFU/day), a low dose (1.8 billion CFU/day), or placebo³. In the high-dose group, whole-gut transit time dropped from 49±30 hours to 21±32 hours before-and-after treatment, and the three-arm comparison was significant (P<.001). A separate time-to-marker-excretion analysis found the high-dose group cleared significantly faster than the low-dose and placebo groups combined (P<.05), though the paper didn't report an isolated high-dose-versus-placebo pairwise comparison. This trial was funded by Fonterra Research Centre. One co-author was affiliated with Fonterra and two with Danisco (HN019's manufacturer at the time); the paper declared no conflicts of interest.

A separate, larger 228-person, 28-day trial using lower doses (1 billion or 10 billion CFU/day) found no significant difference between HN019 and placebo on its primary or secondary endpoints overall⁴. Only in a post-hoc subgroup of people with baseline constipation (fewer than three bowel movements a week, n=65) did pooled HN019 doses improve bowel frequency (P=.01), with straining improvement only in the high-dose group (P=.02). This trial was funded directly by DuPont (HN019's manufacturer by then); two authors were DuPont employees and three worked for Eurofins Optimed, the contract research organization DuPont hired to run the study.

A larger, more recent trial complicates the picture further: 229 adults with functional constipation took HN019 or placebo for eight weeks in a triple-blind design, and the two groups saw similar increases in complete spontaneous bowel movements per week (0.80 versus 0.66), a difference that wasn't statistically significant (P=.37)⁵. This trial was funded in full by Danisco China; co-author Arthur Ouwehand disclosed holding multiple probiotic-related patents licensed to Danisco and DuPont entities, and the paper reported no other author disclosures.

A 2025 multicenter, triple-blind trial across four French clinical centers also found HN019 no better than placebo for functional constipation, with no significant differences in stool or microbiota markers between groups⁶.

A 2024 meta-analysis pooling 10 constipation trials (1,243 people, including the 2018 HN019 trial above) found probiotics overall modestly effective, but flagged very high heterogeneity (I²=95%) and publication bias across the included studies. It summarized the Ibarra HN019 trial as finding no significant differences in its primary or secondary outcomes⁷. That undercuts the FAQ language above, since HN019 is one of the two strains WonderBiotics leads with.

NCFM and LGG (both also in WonderBiotics Gut Health) and BB-12 (in Ritual Synbiotic+). WonderBiotics' blend includes the same L. rhamnosus GG strain Ritual markets as LGG®, alongside NCFM. NCFM, LGG, and BB-12 are all among the most commercially established probiotic strains, with decades of use across different product categories. None of that research was conducted in people taking semaglutide or tirzepatide, and neither brand's product page cites a strain-specific trial measuring bloating or constipation relief in a GLP-1 population.

The evidence gap for GLP-1 users. In our research as of August 2026, no published, placebo-controlled trial has tested any probiotic — HN019, NCFM, LGG, BB-12, or otherwise — specifically in people on GLP-1 medications. The only registered study built for that exact question is a French trial (PROBIO-GLP1, planned enrollment of 50 patients starting GLP-1 receptor agonist therapy) that hadn't begun recruiting as of 2026⁸ — a gap that applies equally to Ritual's formula and ours. Neither brand publishes the individual per-strain CFU dose within its blend, so there's no way to confirm whether HN019's amount in WonderBiotics Gut Health matches the higher, more effective dose used in trials, or whether LGG and BB-12 in Ritual's formula match theirs. Multi-strain probiotic brands generally share this dosing-transparency gap.

Why Constipation, Not Just Nausea, Is the Longer-Running Issue

Wegovy's (semaglutide) label reports nausea in roughly 44% of patients in its adult weight-management trials versus 16% on placebo, and constipation in about 24% versus 11%⁹, though incidence alone doesn't capture how long each symptom lasts. In a pooled analysis of the STEP 1–3 trials, the median episode of nausea lasted about 8 days and vomiting about 2 days. Constipation lasted a median of 47 days on semaglutide versus 35 days on placebo, making it the GI complaint most likely to still be bothering you weeks into treatment¹⁰. It's the slow-burn issue, still present after the first month while nausea and vomiting have typically resolved.

Neither WonderBiotics Gut Health nor Ritual Synbiotic+ is a treatment for GLP-1 side effects, and neither should replace the dose-titration, hydration, fiber, and diet adjustments your prescriber may already be managing with you. Both are daily supplements meant to support a routine.

Side-by-Side Comparison

If you're specifically looking for a gut supplement that acknowledges and is formulated around GLP-1 use, WonderBiotics Probiotics for Gut Health is the more direct fit on strain diversity, CFU total, and the added enzyme support for slower digestion. If you want a simpler two-strain formula with a colon-targeted capsule and aren't looking for GLP-1-specific framing, Ritual Synbiotic+ is a reasonable, well-documented alternative for general gut maintenance — its marketing and research simply don't address GLP-1 side effects.

When to Call Your Doctor Instead of Reaching for a Supplement

Some GI symptoms on GLP-1 medications need medical attention, not a probiotic. Seek care right away for abdominal pain that's severe or radiates to your back with nausea, vomiting, fever, chills, or yellowing skin — these can signal pancreatitis or a gallbladder problem¹¹. Abdominal pain lasting several hours along with fever, chills, dark urine, or pale stools also warrants prompt evaluation for gallstones¹². Severe bloating with an inability to pass gas or stool, persistent vomiting, or abdominal swelling that won't go away can point to a bowel obstruction and should prompt a same-day call to your doctor or a trip to urgent care¹³. If you're also showing signs of significant dehydration — confusion, fainting, or very little urine — that's an emergency room situation¹⁴. None of this is something to manage by adjusting your GLP-1 dose on your own; that decision belongs to your prescriber. If you're immunocompromised or have a central line, talk to your doctor before starting any probiotic, since safety data in those groups is more limited¹⁵.

The Bottom Line

For everyday bloating and constipation support alongside semaglutide or tirzepatide, WonderBiotics Probiotics for Gut Health is the formula actually built for that population, with more strain diversity, a higher CFU count, and an enzyme blend aimed at the slower digestion GLP-1 drugs cause. Ritual Synbiotic+ is a solid, simpler synbiotic for general gut maintenance, but it isn't designed with your specific situation in mind. Either way, treat this as daily support alongside your prescriber's guidance, especially if side effects turn severe enough to need their input.

References

1. Ritual. Synbiotic+. Accessed August 2026.
2. WonderBiotics. Probiotics for Gut Health. Accessed August 2026.
3. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486
4. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, dose-ranging trial. Gut Microbes. 2018;9(3):236-251. PMID 29227175
5. Cheng J, Gao C, Ala-Jaakkola R, et al. Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(10):e2436888. PMID 39356506
6. Ala-Jaakkola R, Forssten SD, Cheng J, et al. Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, Placebo-Controlled Trial. Mol Nutr Food Res. 2025;69(17):e70081. PMID 40320938
7. Garzon Mora N, Jaramillo AP. Effectiveness of Probiotics in Patients With Constipation: A Systematic Review and Meta-Analysis. Cureus. 2024;16(1):e52013. PMID 38344541
8. ClinicalTrials.gov. Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1). NCT07213323, Hospices Civils de Lyon.
9. FDA. Wegovy (semaglutide) Prescribing Information. DailyMed, accessed August 2026.
10. Wharton S, Davies M, Dicker D, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. PMC9293236
11. NIDDK. Pancreatitis: Symptoms & Causes.
12. NIDDK. Gallstones: Symptoms & Causes.
13. MedlinePlus. Intestinal obstruction.
14. Mayo Clinic. Dehydration: Symptoms and causes.
15. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60(Suppl 2):S129-S134. PMID 25922398